Array BioPharma, Inc. (NASDAQ:ARRY)

PIcolano (< 20) Submitted: 12/21/2007 3:38:28 PM : Start Price: $8.67 ARRY Score: -53.12

The depth of Array's pipeline is similar to Exelexis' pipeline, and should pay off handsomely for both companies over the long haul...

SavvyMoneyMan (76.73) Submitted: 10/17/2007 4:28:00 PM : Start Price: $11.95 ARRY Score: -61.24

I decided to Bail on Excel after the failed drug trial so I ended that pick. Then the RuleBreaker newsletter gave me another drug company to replace excel. I really like what rulebreaker says, subscribe to get the details.

RNZ100 (93.32) Submitted: 10/2/2007 8:50:00 PM : Start Price: $10.56 ARRY Score: -57.22

If Celgene believes in them, then so do I!!

rnovelly (< 20) Submitted: 7/4/2007 7:59:54 PM : Start Price: $11.80 ARRY Score: -61.92

Working on major med. breakthroughs.

BIGJIMT (74.16) Submitted: 4/18/2007 9:30:55 PM : Start Price: $13.18 ARRY Score: -69.08

PRODUCT PIPELINE AND HIRING OF DR,SPECTOR TO SEE TO IT THAT THE DRUGS HAVE A BETTER CHANCE OF APPROVAL WITH HIS BACKGROUND. FORMER EMPLOYEE OF GLAXO.
Dr. Spector served as Director of GlaxoSmithKline’s Exploratory Medical Sciences in Oncology, where he successfully developed two important cancer drugs ANOTHER COMPANY IN MUCH BETTER SHAPE ALL AROUND THAN CRAMERS 'NSTK' HYPE COMPANY.

martinlemalin (< 20) Submitted: 1/20/2007 4:34:19 PM : Start Price: $13.00 ARRY Score: -71.39

.. thinking that the health services sector could do well this year (as opposed to metals, banking, oil) ..

msaccomanno (< 20) Submitted: 1/19/2007 10:51:00 PM : Start Price: $13.00 ARRY Score: -71.39

rated best bio-tech stock